bearish
The Chickens Are Ready to Roost
193 Views19 Oct 2016 11:06
Several recent developments confirm our thesis that Inflectra's US sales in 2017 will fall far short of management's 2017 forecast. First, Pfizer's...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
Price Chart(Sign Up to Access)
- The Disconnect Is Growing22 Apr 2017
- Recent Developments Not Encouraging20 Jan 2017
- One World, Two Stories04 Nov 2016
- The Chickens Are Ready to Roost19 Oct 2016
- More Harsh Reality from Teva16 Sep 2016
- Another Payer Speaks Cautiously28 Jul 2016
x